Showing results (161-170 of 1,046) with videos related to

Sort By:
Pageof 105
Vascular Pharmacology|April 2, 2014
Risk prediction with proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with stable coronary disease on statin treatmentChristian Werner, Michael M Hoffmann, Karl Winkler, et al.
Cardiovascular Diabetology|November 20, 2014
Association of secreted frizzled-related protein 4 (SFRP4) with type 2 diabetes in patients with stable coronary artery diseaseMichael M Hoffmann, Christian Werner, Michael Böhm, et al.
Current Pharmaceutical Design|March 23, 2011
Cardiovascular disease and dyslipidemia: beyond LDLJanine Pöss, Florian Custodis, Christian Werner, et al.
International Journal of Heart Failure|October 20, 2022
Optimization of Heart Failure Treatment by Heart Rate ReductionMichael Böhm, Yvonne Bewarder, Ingrid Kindermann, et al.
Biochemical Pharmacology|July 9, 2019
The non-steroidal mineralocorticoid receptor antagonist finerenone prevents cardiac fibrotic remodelingDaniel Lavall, Nadine Jacobs, Felix Mahfoud, et al.
Circulation Research|September 5, 2009
Endogenous activation of mitochondrial KATP channels protects human failing myocardium from hydroxyl radical-induced stunningChristoph Maack, Ewtim R Dabew, Mathias Hohl, et al.
Cardiovascular Research|April 22, 2009
ACE inhibition promotes upregulation of endothelial progenitor cells and neoangiogenesis in cardiac pressure overloadPatrick Müller, Andrey Kazakov, Philippe Jagoda, et al.
Critical Care Medicine|December 4, 2008
Argatroban for anticoagulation in continuous renal replacement therapyAndreas Link, Matthias Girndt, Simina Selejan, et al.
Herzschrittmachertherapie & Elektrophysiologie|May 4, 2023
Pleiotropic effects of NOACs with focus on edoxaban: scientific findings and potential clinical implicationsAndreas Goette, Martin Mollenhauer, Volker Rudolph, et al.
Pageof 105